|
|
 |
 |
|
|
|
|
Trio of failed phase III studies for Pfizer
|
12-Mar-2010
|
Pfizer has announced that it is discontinuing a phase III trial of a drug for non-small cell lung cancer due to disappointing interim data, as well as that two phase III studies of the company’s breast cancer drug Sutent failed to meet their primary endpoints
Read more...
|
|
US News in Brief, March 12, 2010
|
12-Mar-2010
|
People – Coyne PR healthcare director
People – Feintuch managing director
People – Ogilvy senior health hires
Diary - Institute for PR seminar
New JFK Comms client
Watson prostate cancer drug approved
Bayer CF drug wins orphan status
Read more...
|
|
US News in Brief, March 04, 2010
|
04-Mar-2010
|
FDA to collaborate with NIH
People – B + L public relations VP
AstraZeneca on social media
Diary – World Health Care Congress
Abbott partners with GSK
Pfizer Alzheimer's drug disappoints
Bristol-Myers licenses Allergan drug
Read more...
|
|
GSK hits back over Avandia
|
26-Feb-2010
|
GlaxoSmithKline is mounting a strong response to allegations from lawmakers that the company did not properly monitor the safety of its diabetes drug Avandia or share potentially disturbing safety information with the US Food and Drug Administration
Read more...
|
|
US News in Brief, February 26, 2010
|
26-Feb-2010
|
Novartis CML drug wins priority review
Boehringer COPD awareness
Justice Department IP task force
New social media guidelines
Bayer HealthCare taps Omnicom and WPP
Hayden IR wins new business
CCG Investor Relations wins new business
Northwest Biotherapeutics names AOR
People – Ogilvy healthcare head
People – Chamberlain leadership shifts
People - Sepracor CE0 resigns
Read more...
|
|
Merck profits soar post-merger
|
17-Feb-2010
|
Merck has announced dramatic increases in its fourth-quarter profits and revenues, reflecting its recent acquisition of Schering-Plough. Net income for the quarter was $6.49b, or $2.35 per share, compared with $1.64b, or 78 cents a share, in the same quarter last year
Read more...
|
|
US News in Brief, February 17, 2010
|
17-Feb-2010
|
New REMS for anemia drugs
EntreMed drug wins orphan status
Abbott completes Solvay buy
Novartis MS outreach
Diary – PR Council Leadership Program
Diary- Off-label promotions audioconference
Diary – HBA Awards
Diary – PRSA Foundation Award
People – Porter Novelli EVP
People - Merck Consumer Health president
Read more...
|
|
Idaho bucks health reform efforts
|
10-Feb-2010
|
Idaho lawmakers have taken a stance against the federal government’s efforts at health care reform, with a high-profile measure passing in the state’s House of Representatives that would require the state to sue the US government over any health insurance mandates
Read more...
|
|
US News in Brief, February 10, 2010
|
10-Feb-2010
|
FDA to streamline device trials
Market Media Connect account win
Palio social media service
King Pharma pain awareness program
Lundbeck rare diseases campaign
Sanofi-aventis buys Chattem
People – ApotheCom CEO
Read more...
|
|
Orphan drugs on the rise
|
03-Feb-2010
|
The number of orphan product designations granted by the US Food and Drug Administration has more than doubled in recent years, reflecting the growing importance in the pharma and biotech industries of therapies designed for smaller, targeted markets, according to a new report from Tufts University’s Center for the Study of Drug Development
Read more...
|
|
|
Page 1 2 
|
 |
|
|
|
|
